Mettler-Toledo International Inc. (NYSE:MTD) Shares Purchased by Albert D Mason Inc.

Albert D Mason Inc. raised its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 3.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,255 shares of the medical instruments supplier’s stock after buying an additional 41 shares during the quarter. Albert D Mason Inc.’s holdings in Mettler-Toledo International were worth $1,482,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of MTD. Allworth Financial LP lifted its position in shares of Mettler-Toledo International by 367.4% during the fourth quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier’s stock worth $285,000 after purchasing an additional 169 shares in the last quarter. Royal Bank of Canada increased its stake in Mettler-Toledo International by 7.3% in the fourth quarter. Royal Bank of Canada now owns 45,756 shares of the medical instruments supplier’s stock valued at $55,990,000 after purchasing an additional 3,105 shares during the last quarter. Impax Asset Management Group plc increased its stake in Mettler-Toledo International by 5.8% in the fourth quarter. Impax Asset Management Group plc now owns 198,852 shares of the medical instruments supplier’s stock valued at $243,331,000 after purchasing an additional 10,830 shares during the last quarter. Renaissance Technologies LLC increased its stake in Mettler-Toledo International by 31.3% in the fourth quarter. Renaissance Technologies LLC now owns 12,600 shares of the medical instruments supplier’s stock valued at $15,418,000 after purchasing an additional 3,000 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its holdings in shares of Mettler-Toledo International by 13.9% in the fourth quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier’s stock valued at $335,977,000 after acquiring an additional 33,456 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock opened at $1,190.52 on Friday. The stock’s 50 day moving average price is $1,101.85 and its 200 day moving average price is $1,204.77. The firm has a market capitalization of $24.74 billion, a PE ratio of 29.37, a price-to-earnings-growth ratio of 3.30 and a beta of 1.38. Mettler-Toledo International Inc. has a one year low of $946.69 and a one year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, topping the consensus estimate of $7.90 by $0.29. The firm had revenue of $883.74 million for the quarter, compared to analyst estimates of $876.61 million. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. Mettler-Toledo International’s revenue for the quarter was down 4.6% on a year-over-year basis. During the same period in the previous year, the company posted $8.89 EPS. On average, analysts forecast that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of Mettler-Toledo International stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the sale, the director now directly owns 120 shares in the company, valued at $139,191.60. The trade was a 89.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.94% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Citigroup raised Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,400.00 price target for the company in a report on Monday, April 7th. Jefferies Financial Group raised Mettler-Toledo International from an “underperform” rating to a “hold” rating and cut their price target for the stock from $1,200.00 to $1,110.00 in a research note on Monday, May 5th. Wells Fargo & Company lifted their price objective on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an “equal weight” rating in a research report on Monday, May 5th. UBS Group upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating and lowered their price target for the company from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Finally, Robert W. Baird lowered their price target on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a “neutral” rating for the company in a report on Tuesday, April 22nd. Seven research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $1,302.11.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.